Karen Prange Atri Cure, Inc. (ATRC) insider trading activity

ATRC Quotes by TradingView

Karen Prange is Director of AtriCure, Inc.. Currently has a direct ownership of 23,928 shares of ATRC, which is worth approximately $532,158. The most recent transaction as insider was on May 13, 2024, when has been sold 7,788 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 23.9K
48.25% 3M change
48.25% 12M change
Total Value Held $532,158

Karen Prange Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 13 2024
BUY
Grant, award, or other acquisition
-
7,788 Added 24.56%
23,928 Common Stock
Jun 08 2023
SELL
Open market or private sale
$34,145 $47.89 p/Share
713 Reduced 4.23%
16,140 Common Stock
May 25 2023
BUY
Grant, award, or other acquisition
-
3,186 Added 15.9%
16,853 Common Stock
May 25 2022
BUY
Grant, award, or other acquisition
-
3,564 Added 20.68%
13,667 Common Stock
May 20 2021
BUY
Grant, award, or other acquisition
-
1,749 Added 14.76%
10,103 Common Stock

Also insider at

NVRO
NEVRO CORP Healthcare
VRAY
ViewRay, Inc. Healthcare
Director
EMBC
Embecta Corp. Healthcare
Director
KP

Karen Prange

Director
Mason, OH

Track Institutional and Insider Activities on ATRC

Follow AtriCure, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ATRC shares.

Notify only if

Insider Trading

Get notified when an Atri Cure, Inc. insider buys or sells ATRC shares.

Notify only if

News

Receive news related to AtriCure, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ATRC